Litcius/Paper detail

GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders

Divya Soni, Puneet Kumar

2022Pharmacological Reports35 citationsDOI

Topics & Concepts

NeuroprotectionChoreaMovement disordersOxidative stressGSK-3AtaxiaParkinson's diseaseNeuroscienceMedicineBiologySignal transductionPharmacologyInternal medicineCell biologyDiseaseParkinson's Disease Mechanisms and TreatmentsCoenzyme Q10 studies and effectsAmyotrophic Lateral Sclerosis Research
GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders | Litcius